Robert Flanagan Overview
- Firm
- Clark Enterprise...
- Primary Position
-
Chair of the Boa...
- Primary Industry
-
Healthcare
- Active Board Seats
-
5
- Med. Deal Size
-
- Med. Valuation
-
Robert Flanagan General Information
Biography
Mr. Robert Flanagan serves as Chair of the Board & Executive Vice President at Clark Enterprises. He serves as Board Member & Chair of the Governance Committee at Brown Advisory. He served as Managing Director at CNF Investments. He also serves as a Board Member at A. James & Alice B. Clark Foundation. He served as a Board Member at Svelte Medical Systems. He is Chairman of the Board of Directors of the Federal City Council, Washington, DC. Mr. Flanagan is also a member of the Board of Advisors of Georgetown University's McDonough School of Business. Mr. Flanagan was Chairman of the Board of Directors of Martek Biosciences Corporation (NASDAQ: MATK) and Sagent Pharmaceuticals (NASDAQ: SGNT) and was Treasurer, Secretary and a member of the Board of Directors of Baltimore Orioles, Inc. Mr. Flanagan received a BS in Business Administration from Georgetown University, an MST from the American University School of Business and is a Certified Public Accountant licensed in Washington, DC.
Contact Information
Address
- 7500 Old Georgetown Road
- Suite 15
- Bethesda, MD 20814
- United States
Robert Flanagan Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Clark Enterprises | Investor | Chair of the Board & Executive Vice President | Bethesda, MD | PE/Buyout |
Robert Flanagan Board Seats (5)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| A. James & Alice B. Clark Foundation | Chevy Chase, MD | ||||
| Brown Advisory | Other Financial Services | Privately Held (backing) | Formerly PE-Backed | Baltimore, MD | |
| Clark Enterprises | Other Financial Services | Privately Held (no backing) | Corporation | Bethesda, MD | |
| Vascular Therapies | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Cresskill, NJ | |
| Verax Biomedical | Diagnostic Equipment | Privately Held (backing) | Venture Capital-Backed | Marlborough, MA |
Robert Flanagan Lead Partner on Deals (14)
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Vascular Therapies | 14-Dec-2016 | Later Stage VC (Series E) | Completed | Drug Discovery | Cresskill, NJ | |
| Svelte Medical Systems | 25-Jul-2016 | Completed | Therapeutic Devices | New Providence, NJ | ||
| Verax Biomedical | 27-Jun-2016 | Completed | Diagnostic Equipment | Marlborough, MA | ||
| ViewLift | 28-Mar-2016 | Completed | Entertainment Software | New York, NY | ||
| ViewLift | 28-Mar-2016 | Completed | Entertainment Software | New York, NY | ||
| Svelte Medical Systems | 10-Mar-2014 | Completed | Therapeutic Devices | New Providence, NJ | ||
| Verax Biomedical | 22-Mar-2011 | Completed | Diagnostic Equipment | Marlborough, MA | ||
| Brown Advisory | 19-Jun-2010 | Completed | Other Financial Services | Baltimore, MD | ||
| Svelte Medical Systems | 07-Dec-2009 | Early Stage VC (Series A) | Completed | Therapeutic Devices | New Providence, NJ | |
| Svelte Medical Systems | 15-May-2009 | Early Stage VC (Series A) | Completed | Therapeutic Devices | New Providence, NJ |
Robert Flanagan Network (222)
Board Members (81)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Daniel Ryan | Vascular Therapies | The Spring Bay Companies | Cresskill, NJ | |
| Simon Zoete | Brown Advisory | Brown Advisory | Baltimore, MD | |
| Verax Biomedical | Verax Biomedical | Marlborough, MA | ||
| Vascular Therapies | New Science Ventures | Cresskill, NJ | ||
| Vascular Therapies | Self | Cresskill, NJ |
Portfolio Executives (139)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| John McDermott | Vascular Therapies | Chief Executive Officer & Board Member | 14-Dec-2016 | Cresskill, NJ |
| Sriram Iyer MD | Vascular Therapies | Founder, Chief Scientific Officer & Board Member | 14-Dec-2016 | Cresskill, NJ |
| Vascular Therapies | Vice President, New Product Development | 14-Dec-2016 | Cresskill, NJ | |
| Vascular Therapies | Vice President of Regulatory Affairs | 14-Dec-2016 | Cresskill, NJ | |
| Vascular Therapies | Vice President, Quality Assurance | 14-Dec-2016 | Cresskill, NJ |
Fund Team Members (2)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| CNF Investments | Bethesda, MD | ||
| CNF Investments | Bethesda, MD |
Robert Flanagan Affiliated Funds (1)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| CNF Investments II | CNF Investments | Buyout | Liquidated | 2012 |
Robert Flanagan FAQs
-
Who is Robert Flanagan?
Mr. Robert Flanagan serves as Chair of the Board & Executive Vice President at Clark Enterprises.
-
How much does Robert Flanagan typically invest?
Robert Flanagan's median deal size is .
-
What is Robert Flanagan’s main position?
Robert Flanagan’s primary position is Chair of the Board & Executive Vice President.
-
What are the contact details for Robert Flanagan?
Robert Flanagan’s email address is ro and his phone number is +1 (301) .
-
How many active board seats does Robert Flanagan hold?
Robert Flanagan holds 5 board seats including A. James & Alice B. Clark Foundation, Brown Advisory, Clark Enterprises, Vascular Therapies, and Verax Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
